0.1306
price down icon0.76%   -0.001
 
loading

Prophase Labs Inc Borsa (PRPH) Ultime notizie

pulisher
02:01 AM

Is ProPhase Labs Inc. stock a buy in volatile marketsIPO Watch & Technical Entry and Exit Tips - Newser

02:01 AM
pulisher
Nov 27, 2025

MSN Money - MSN

Nov 27, 2025
pulisher
Nov 27, 2025

Will Fed Rate Hikes Affect Kridhan Infra Limited Stocks OutlookValue Traps to Avoid & Get Free Expert Trading Recommendations - earlytimes.in

Nov 27, 2025
pulisher
Nov 26, 2025

ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... By GuruFocus - Investing.com Canada

Nov 26, 2025
pulisher
Nov 26, 2025

ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strat - GuruFocus

Nov 26, 2025
pulisher
Nov 26, 2025

ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... - Yahoo Finance

Nov 26, 2025
pulisher
Nov 26, 2025

Prophase Labs Secures Forbearance Agreement with Avtech Capital - MSN

Nov 26, 2025
pulisher
Nov 26, 2025

Prophase Labs Faces Unsealed Civil Action Disclosure - MSN

Nov 26, 2025
pulisher
Nov 26, 2025

ProPhase Labs stockholders approve digital asset initiatives and stock split authority - Investing.com Australia

Nov 26, 2025
pulisher
Nov 26, 2025

Prophase Labs Approves Strategic Proposals at Special Meeting - TipRanks

Nov 26, 2025
pulisher
Nov 26, 2025

ProPhase Labs stockholders approve digital asset initiatives and stock split authority By Investing.com - Investing.com South Africa

Nov 26, 2025
pulisher
Nov 26, 2025

ProPhase Labs investors approve digital asset powers and stock split plan - Stock Titan

Nov 26, 2025
pulisher
Nov 26, 2025

ProPhase Labs (NASDAQ: PRPH) to Detail BE-Smart Cancer Test, $7–14B Market Opportunity - Stock Titan

Nov 26, 2025
pulisher
Nov 26, 2025

Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1 - Sahm

Nov 26, 2025
pulisher
Nov 25, 2025

ProPhase Labs discloses unsealing of False Claims Act lawsuit in New York - Investing.com Nigeria

Nov 25, 2025
pulisher
Nov 25, 2025

ProPhase Labs discloses unsealing of False Claims Act lawsuit in New York By Investing.com - Investing.com South Africa

Nov 25, 2025
pulisher
Nov 25, 2025

ProPhase Labs updates payment schedule on Avtech equipment lease following Utah judgment - Investing.com Nigeria

Nov 25, 2025
pulisher
Nov 25, 2025

ProPhase LabsOn Nov 21, received confirmation from AVTECH agreeing to continue its forbearance under co's existing equipment lease - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

ProPhase Labs updates payment schedule on Avtech equipment lease following Utah judgment By Investing.com - Investing.com South Africa

Nov 25, 2025
pulisher
Nov 25, 2025

ProPhase Labs aware that civil action pending in the United States District Court for the Eastern District of New York has been unsealed - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

Prophase Labs- On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment Lease - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

[8-K] ProPhase Labs, Inc. Reports Material Event | PRPH SEC FilingForm 8-K - Stock Titan

Nov 25, 2025
pulisher
Nov 21, 2025

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2025 Earnings Call Transcript - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances - MSN

Nov 21, 2025
pulisher
Nov 20, 2025

Is ProPhase Labs Inc. stock vulnerable to regulatory risksForecast Cut & Advanced Technical Analysis Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Reversal indicators forming on ProPhase Labs Inc. stock2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs Reports Q3 Loss Amid Strategic Shifts - TipRanks

Nov 19, 2025
pulisher
Nov 19, 2025

Earnings call transcript: ProPhase Labs Q3 2025 posts unexpected EPS loss - Investing.com Nigeria

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs’ Earnings Call: Challenges and Opportunities - The Globe and Mail

Nov 19, 2025
pulisher
Nov 19, 2025

What data driven models say about ProPhase Labs Inc.’s future - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs Q3 2025 Earnings Call Transcript - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

[10-Q] ProPhase Labs, Inc. Quarterly Earnings Report | PRPH SEC FilingForm 10-Q - Stock Titan

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs in talks for strategic initiative, cites undervalued assets By Investing.com - Investing.com Nigeria

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:PRPH) 2025-11-19 - Seeking Alpha

Nov 19, 2025
pulisher
Nov 19, 2025

Prophase Labs Unveils Strategic Initiatives and Partnerships - MSN

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025 - marketscreener.com

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs reported results for the third quarter ended September 30, 2025, and will hold a virtual conference call today at 2pm ET. - marketscreener.com

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs (PRPH) Explores Strategic M&A Opportunities - GuruFocus

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs (PRPH) Q3 Revenue Decline but Future Prospects Bri - GuruFocus

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. - The Manila Times

Nov 19, 2025
pulisher
Nov 19, 2025

ProPhase Labs in talks for strategic initiative, cites undervalued assets - Investing.com

Nov 19, 2025
diagnostics_research DGX
$182.72
price down icon 0.68%
diagnostics_research LH
$258.93
price down icon 0.98%
diagnostics_research WAT
$397.43
price up icon 0.30%
diagnostics_research MTD
$1,414.67
price down icon 0.53%
$244.16
price up icon 0.49%
diagnostics_research IQV
$225.39
price up icon 0.23%
Capitalizzazione:     |  Volume (24 ore):